PMA Apr 28, 2020 Caris Life Sciences Seeks FDA Approval for Exome, Transcriptome CDx Assays Feb 11, 2020 Myriad Files sPMA With FDA for Test to ID Best Responders to Lynparza, Avastin Combination Jan 23, 2020 Myriad Genetics Seeks Supplemental Approval of HRD Test as CDx for GSK Ovarian Cancer Drug Aug 7, 2019 Myriad Genetics Seeking Additional FDA Approval for BRACAnalysis CDx Apr 9, 2019 Myriad Submits MyChoice HRD as Companion Diagnostic for GSK's Zejula Oct 16, 2018 FDA Approves Myriad Genetics BRCA CDx With Pfizer's Metastatic Breast Cancer Drug Apr 19, 2018 FDA Expands Approval of Roche Cobas Test as CDx for EGFR Deletions, Mutations Jun 22, 2017 Thermo Fisher Next-Gen Sequencing Panel Wins FDA Approval as Companion Test Breaking News Marengo Therapeutics Begins Phase I/II Trial of Selective T-Cell-Targeted Antibody Janssen, Legend Biotech's Carvykti Bests Chemo in Earlier-Line Multiple Myeloma Trial In Brief This Week: PreludeDx, Johnson & Johnson, Syros, Magenta, Merck NICE Backs Gilead Sciences' Yescarta as Third-Line Option for Lymphoma Patients BMS Eyeing Breyanzi Indications in CLL, SLL After Positive Trial Data Enhertu Approved in Europe for HER2-Low Metastatic Breast Cancer
